HBOT and Stroke Recovery: Timing, Evidence and What to Expect
By Oxyplus — Newcastle's Specialist Hyperbaric Oxygen Therapy Clinic oxyplus.co.uk | Updated July 2026 | 9 min read
One of the most persistent and damaging myths in stroke rehabilitation is that recovery has a hard ceiling, that after a certain point, usually measured in weeks or months, the brain's capacity to heal is exhausted and the deficits that remain are permanent.
The science has been quietly dismantling this idea for years. And hyperbaric oxygen therapy (HBOT) sits at the centre of some of the most important evidence challenging it.
At OxyPlus, our HBOT clinic in Newcastle, we work with stroke survivors at various stages of recovery, from the weeks immediately following an acute event to people living with the effects of a stroke that happened years ago. The evidence for HBOT in this context is more substantial than most people know, and the biological rationale is one of the most coherent in all of HBOT medicine.
This post explains what happens in the brain after a stroke, why oxygen is so central to the recovery process, what the clinical trials have found, and why timing, while important, may matter less than you've been told.
What Happens in the Brain After a Stroke
A stroke occurs when blood flow to part of the brain is interrupted, either by a blockage (ischaemic stroke, accounting for around 85% of cases) or by bleeding (haemorrhagic stroke). Within minutes of the blood supply being cut off, brain cells begin to die. This is the infarct, the area of permanent damage at the core of the stroke.
But surrounding this core is something far more important for recovery: a significant area of brain tissue surrounding the damaged region, known as the ischaemic penumbra, contains dormant or "stunned" neurons that remain alive but non-functional.
The terms "chronic penumbra" and "stunned brain" refer to regions with critically reduced cerebral blood flow, abolished synaptic activity, and preserved structural integrity. These regions, which are damaged but not necrotic after stroke, hold therapeutic potential, as proper intervention may restore their function. Advanced imaging techniques further reveal that stunned brain tissue can persist for months to years following an acute ischaemic event.
This is the critical insight. The neurons in the penumbra are not dead, they are metabolically suppressed. They have shut down to conserve the energy they cannot produce because their oxygen supply has been cut. They persist in this state, alive but functionally silent, for months and, in some cases, years after the stroke.
It was proposed that the oxygen supply to these under-active neurons was low due to stroke damage to blood vessels in these regions, leading to oxygen deficiency, anaerobic metabolism and ATP depletion.
This is exactly the problem HBOT is designed to address.
Why Oxygen Is the Key
The pressurised environment of HBOT forces oxygen into the blood plasma, cerebrospinal fluid, and lymph fluids, delivering dramatically higher concentrations of oxygen to oxygen-starved brain tissue. This increased oxygen supply helps reactivate dormant neurons in the penumbra region.
At 2.4 ATA with 100% oxygen, the standard clinical HBOT protocol, the plasma oxygen partial pressure rises above 1,110 mmHg, making it reasonable to expect that HBOT can be an efficient and clinically feasible method for increasing tissue and cellular oxygenation, effectively evoking neuroplasticity in the chronically non-active areas during the late post-stroke phase.
The mechanism is elegant in its simplicity: neurons in the penumbra have fallen silent because they cannot produce enough ATP to maintain function. ATP production requires oxygen. HBOT delivers oxygen to exactly these cells, dissolved directly in plasma, bypassing the disrupted blood vessel architecture, and gives them the fuel they need to resume activity.
But HBOT's role in stroke recovery is not only about acute oxygenation. It triggers a cascade of neuroplastic processes that extend far beyond the session itself.
The Science: How HBOT Supports Stroke Recovery
1. Reactivating Stunned Neurons - Neuroplasticity in Action
SPECT imaging reveals that HBOT induces the reactivation of neuronal activity in metabolically stunned brain regions.
This is not theoretical - it is directly observable on brain imaging. SPECT scans taken before and after HBOT courses show measurable increases in metabolic activity in brain regions that were previously hypoactive, corresponding with clinical improvements in motor function, language, and cognition.
Repeated HBOT sessions significantly enhance neuroplasticity in regions of viable but hypoactive neurons, driving neurological improvements in patients with late chronic-stage stroke.
HBOT can promote brain recovery and neuroplasticity through the modulation of key cellular and molecular mechanisms. A randomised, prospective trial of 40 daily sessions of HBOT over 2 months in post-stroke patients showed a significant improvement in the neurological functions and life quality of all patients in both treated and cross control groups after undergoing HBOT therapy.
2. Angiogenesis - Building New Blood Supply
HBOT can influence HIF-1 levels, matrix metalloproteinase activity, and VEGF. It can induce stem cell proliferation, increase circulating levels of endothelial progenitor cells, and promote angiogenesis itself, enhancing blood flow in ischaemic areas.
The formation of new blood vessels around and through the area of stroke damage is one of the most important factors in long-term recovery. Angiogenesis restores the structural basis for sustained oxygenation - meaning the benefits of HBOT extend beyond the treatment period as new vascular networks become established.
3. Reducing Neuroinflammation and Oedema
HBOT modulates inflammatory responses and reduces oxidative stress, which are known to inhibit neuroplasticity and impair recovery following stroke. By attenuating neuroinflammation and promoting antioxidant defences, HBOT creates a conducive environment for synaptic plasticity and neuronal remodelling, fostering recovery of motor and cognitive functions in stroke survivors.
Post-stroke neuroinflammation is one of the primary barriers to recovery. Inflammatory cytokines damage surrounding tissue, suppress neuroplasticity, and perpetuate the cycle of dysfunction in the penumbra. HBOT addresses this through the same anti-inflammatory mechanisms it applies in other conditions, see our post on HBOT and Inflammation for a fuller discussion of these pathways.
4. Neurogenesis and Synaptogenesis
HBOT can promote brain recovery and neuroplasticity through the modulation of key cellular and molecular mechanisms, including neurogenesis via upregulation of Wnt-3 and VEGF/ERK signalling, synaptogenesis through elevated GAP43 and synaptophysin expression, and anti-inflammatory responses.
These are not just laboratory findings. The clinical correlates, improvements in language, memory, motor co-ordination, and emotional regulation, map directly onto the brain regions where these neuroplastic processes are occurring.
5. Post-Stroke Depression and Quality of Life
In post-stroke chronic patients, HBOT induced significant changes in neurological function, neurocognitive recovery, post-stroke depression, and sleep and quality of life.
Post-stroke depression affects around a third of stroke survivors and is one of the most significant barriers to rehabilitation engagement and outcome. The fact that HBOT has documented effects on mood alongside its neurological benefits, through the same mechanisms it uses in brain health more broadly, makes it a particularly holistic addition to a post-stroke care plan.
The Landmark Clinical Trial
The most important clinical evidence for HBOT in stroke recovery comes from a prospective, randomised, controlled trial published in PLOS ONE, conducted by the Sagol Center for Hyperbaric Medicine in Israel.
The trial enrolled 74 post-stroke patients (with 15 excluded), all of whom had suffered a stroke 6–36 months prior to inclusion and had at least one motor dysfunction. Patients were randomly assigned to treated or cross-control groups. Brain activity was assessed by SPECT imaging; neurological functions were evaluated by NIHSS, ADL, and life quality measures.
The HBOT protocol was 40 sessions over 2 months, 5 days per week, 90 minutes per session, at 2 ATA with 100% oxygen.
After HBOT, the cross group demonstrated 43% significant improvement and 29% mild improvement in SPECT imaging. The improvements were mostly in regions showing noticeable discrepancy between CT and SPECT - the metabolically stunned areas, not the infarcted core.
The clinical implications were equally striking. Patients showed significant improvements in NIHSS neurological scores, activities of daily living, and quality of life measures. And crucially, the patients in this trial were not in the acute phase. They were 6–36 months post-stroke, a period conventionally considered beyond the window for meaningful neurological recovery.
This trial challenges, with hard clinical and imaging evidence, the assumption that stroke recovery is time-limited in the way traditional rehabilitation models suggest.
The Timing Question: When Is the Right Time to Start HBOT?
This is the question most stroke survivors and their families ask first, and it deserves a careful answer.
Acute Phase (Days 1-14)
HBOT in the immediate aftermath of stroke is still largely exploratory in clinical practice, though a 2024 systematic review and meta-analysis published in BMC Neurology examined its use in acute ischaemic stroke and found evidence of benefit in reducing infarct volume and improving neurological outcomes. The practical challenge in the acute phase is that patients are typically in hospital managing the medical aspects of the event, tPA administration, monitoring, secondary prevention, and the logistics of accessing HBOT are complex.
A challenging question concerns the optimal time lapse after stroke to start the HBOT procedure. It should be kept in mind that signals and chemical cues associated with cell death during the acute stage of stroke might, in fact, promote repair during recovery, and can be negatively affected by premature application of HBOT. Unlike in preclinical animal studies, in clinical practice it is not feasible to apply HBOT immediately at stroke onset.
In short: the acute window is being studied, but most clinical HBOT work in stroke focuses on the subacute and chronic phases.
Subacute Phase (2 Weeks-6 Months)
This is broadly considered the optimal window for neuroplastic intervention, the brain's own repair mechanisms are most active, and HBOT can amplify and extend these processes. The dramatic spontaneous recovery from stroke occurs mainly within the first 30 days, though moderate and severe stroke survivors continue to improve for at least 90 days. Most of the recovery involves brain regions rendered dysfunctional but not dead.
Beginning HBOT in this window, alongside physiotherapy and occupational therapy, offers the best opportunity to accelerate and deepen the neuroplastic recovery that is already underway.
Chronic Phase (6 Months and Beyond)
This is where HBOT's most surprising and perhaps most clinically important finding lies. The Israeli landmark trial enrolled patients 6–36 months post-stroke, well beyond the window that conventional rehabilitation considers meaningful. And it found significant, measurable improvements.
These findings challenge the notion of a limited post-stroke recovery window, supporting the hypothesis that neuroplasticity can be reactivated months to years after the acute event.
The stunned neurons of the chronic penumbra do not simply disappear after the conventional recovery window closes. They persist metabolically suppressed but structurally intact and HBOT can wake them up. For stroke survivors who were told years ago that their recovery had plateaued, this is one of the most meaningful findings in modern stroke rehabilitation research.
A compelling case report published in Frontiers in Neurology documented a 61-year-old man with severe right hemiparesis and cognitive impairment two years after a left frontal ischaemic stroke. Following HBOT, his Fugl-Meyer Assessment (FMA) score improved from 17 (severe impairment) to 31 (moderate impairment). Following the intervention, there was an observed increase in fMRI activation in both the supplementary motor area and related regions - objective, imaging-confirmed evidence of neurological recovery two years post-stroke.
What Improvements Can Be Expected?
Based on the clinical evidence, the areas most consistently showing improvement following HBOT in post-stroke patients are:
Motor function - particularly upper limb function, gait, and fine motor co-ordination. The fMRI and SPECT data confirm that motor cortex regions are among those most responsive to HBOT-induced reactivation.
Cognitive function - memory, attention, and information processing speed. Current research priorities centre on elucidating HBOT's effects on cognitive recovery in stroke patients, reflecting its therapeutic potential in neurorehabilitation.
Language and communication - in patients with aphasia, improvements in language function have been documented, corresponding with increased metabolic activity in language-associated brain regions.
Activities of daily living (ADL) - the practical independence measures that most directly affect quality of life show consistent improvement in clinical trials.
Mood and emotional wellbeing - post-stroke depression and emotional lability respond alongside the neurological improvements.
Sleep quality - consistently reported as improving across HBOT courses, with significant implications for neurological recovery given the role of sleep in brain repair.
Important Caveats
HBOT is not a guaranteed path to full recovery after stroke, and the degree of improvement depends on multiple factors: the size and location of the infarct, the time elapsed since the stroke, the patient's overall health, and the consistency and completeness of the HBOT course.
HBOT works most powerfully on the penumbra - the stunned but living tissue. Where neurons are permanently lost (the infarcted core), HBOT cannot reverse that damage. The question for each individual patient is how much penumbra remains, how viable it is, and whether HBOT can reach and reactivate it.
We always recommend HBOT as an adjunct to conventional stroke rehabilitation, physiotherapy, occupational therapy, speech and language therapy, not a replacement for it. The evidence suggests HBOT and rehabilitation work synergistically: HBOT creates the neurological conditions for recovery; rehabilitation gives the brain the specific stimuli needed to consolidate that recovery into function.
HBOT for Stroke Recovery in Newcastle - What to Expect at OxyPlus
At OxyPlus, Newcastle's specialist HBOT clinic, here is how we approach post-stroke recovery:
Initial Consultation - We review your stroke history, current neurological status, what rehabilitation you have received, and what deficits remain. For stroke patients with complex medical histories, we will liaise with your GP or neurologist as appropriate.
Personalised Protocol - Based on the clinical trial evidence, 40 sessions is the protocol most strongly supported for post-stroke neuroplastic recovery. We will discuss frequency, timing, and session length (typically 90 minutes) during your consultation.
Combination with Rehabilitation - We actively encourage clients to continue physiotherapy, occupational therapy, and other rehabilitation alongside HBOT. The combination is where the greatest gains are typically seen.
Progress Monitoring - We track your neurological and functional progress throughout the course and maintain open communication about what is happening and what to expect.
We serve clients across Newcastle and the wider North East - including Gateshead, Sunderland, Durham, Northumberland, and Teesside.
Frequently Asked Questions
-
A: The landmark Israeli RCT enrolled patients 6–36 months post-stroke and found significant neurological improvements, and the imaging data showed that the stunned penumbra tissue remained viable and responsive to HBOT even at this timeframe. Individual case reports document meaningful recovery two or more years after stroke. It is worth a consultation to assess your specific situation.
-
A: The majority of the clinical evidence, including the landmark PLOS ONE trial, focuses on ischaemic stroke. Haemorrhagic stroke has different underlying pathology, and HBOT is generally not recommended in the immediate post-haemorrhagic phase. We discuss individual circumstances during consultation and always liaise with the neurological team where appropriate.
-
A: The clinical trial evidence is centred on 40 sessions at 90 minutes per session, 5 days per week over 8 weeks, at 2 ATA with 100% oxygen. At OxyPlus Newcastle, we discuss individual protocols based on your specific presentation and goals.
-
A: Yes, language function is among the areas that have shown improvement in post-stroke HBOT cases, corresponding with increased metabolic activity in language-related brain regions on imaging. It is typically used alongside speech and language therapy for the best outcomes.
-
A: Clinical research has documented improvements in post-stroke depression following HBOT, alongside the neurological recovery. This reflects HBOT's direct action on the brain regions and neurotransmitter systems involved in mood regulation, not simply a secondary effect of improved physical function.
-
A: OxyPlus is Newcastle's specialist HBOT clinic, offering medical-grade hyperbaric oxygen therapy with thorough clinical consultations. We serve clients across Newcastle, Gateshead, Sunderland, Durham, Northumberland, and Teesside. Visit oxyplus.co.uk to book your initial consultation.
The Bottom Line
The idea that stroke recovery is finished after a few weeks or months is one of the most consequential misconceptions in neurology, and the evidence from HBOT research is one of the clearest arguments against it.
Stunned neurons in the ischaemic penumbra can remain viable for months and years. HBOT can reach them with oxygen when disrupted blood vessels cannot. The clinical trials confirm meaningful neurological improvement at timeframes that conventional rehabilitation has written off.
For stroke survivors in Newcastle and the North East, whether recently diagnosed or living with the consequences of a stroke that happened years ago, HBOT is worth a serious, evidence-based conversation.